申请人:The Trustees of the University of Pennsylvania
公开号:US20130165488A1
公开(公告)日:2013-06-27
The present invention relates to novel TP receptor antagonists, which optionally cross the blood-brain barrier of a mammal. The invention also provides methods for treating a disorder related to activation of TP receptor utilizing the compounds of the invention.
本发明涉及一种新型的TP受体拮抗剂,该拮抗剂可以选择性地穿越哺乳动物的血脑屏障。该发明还提供了使用该发明化合物治疗与TP受体激活相关的疾病的方法。